Tag: heparin-induced-thrombocytopenia

Picture Gallery Venture Capital

Akers Biosciences to Commercialize Heparin PF4 Rapid Test in Puerto Rico

April 10, 2017
Presse

Large New U.S-aligned Market Opportunity

Continue Reading
Venture Capital

Akers Biosciences Signs 3-year Agreement with Greater New York Hospital Association for Heparin PF4 Rapid Test

December 19, 2016
Presse

THOROFARE, NJ -- (Marketwired) -- 12/19/16 -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (the "Company"…

Continue Reading